302 related articles for article (PubMed ID: 27351923)
1. Induction of Myeloid-Derived Suppressor Cells in Cryopyrin-Associated Periodic Syndromes.
Ballbach M; Hall T; Brand A; Neri D; Singh A; Schaefer I; Herrmann E; Hansmann S; Handgretinger R; Kuemmerle-Deschner J; Hartl D; Rieber N
J Innate Immun; 2016; 8(5):493-506. PubMed ID: 27351923
[TBL] [Abstract][Full Text] [Related]
2.
Nakanishi H; Kawashima Y; Kurima K; Chae JJ; Ross AM; Pinto-Patarroyo G; Patel SK; Muskett JA; Ratay JS; Chattaraj P; Park YH; Grevich S; Brewer CC; Hoa M; Kim HJ; Butman JA; Broderick L; Hoffman HM; Aksentijevich I; Kastner DL; Goldbach-Mansky R; Griffith AJ
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7766-E7775. PubMed ID: 28847925
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Molecular Phenotypes of Low-Penetrance Variants of NLRP3: Diagnostic and Therapeutic Challenges.
Kuemmerle-Deschner JB; Verma D; Endres T; Broderick L; de Jesus AA; Hofer F; Blank N; Krause K; Rietschel C; Horneff G; Aksentijevich I; Lohse P; Goldbach-Mansky R; Hoffman HM; Benseler SM
Arthritis Rheumatol; 2017 Nov; 69(11):2233-2240. PubMed ID: 28692792
[TBL] [Abstract][Full Text] [Related]
4. CANE, a Component of the NLRP3 Inflammasome, Promotes Inflammasome Activation.
Kaneko N; Kurata M; Yamamoto T; Sakamoto A; Takada Y; Kosako H; Takeda H; Sawasaki T; Masumoto J
J Immunol; 2024 Jul; 213(1):86-95. PubMed ID: 38787200
[TBL] [Abstract][Full Text] [Related]
5. A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors.
Bertoni A; Carta S; Baldovini C; Penco F; Balza E; Borghini S; Di Duca M; Ognio E; Signori A; Nozza P; Schena F; Castellani P; Pastorino C; Perrone C; Obici L; Martini A; Ceccherini I; Gattorno M; Rubartelli A; Chiesa S
J Allergy Clin Immunol; 2020 Jan; 145(1):368-378.e13. PubMed ID: 31194989
[TBL] [Abstract][Full Text] [Related]
6. CAPS and NLRP3.
Booshehri LM; Hoffman HM
J Clin Immunol; 2019 Apr; 39(3):277-286. PubMed ID: 31077002
[TBL] [Abstract][Full Text] [Related]
7. Nlrp3 inflammasome activation in macrophages suffices for inducing autoinflammation in mice.
Frising UC; Ribo S; Doglio MG; Malissen B; van Loo G; Wullaert A
EMBO Rep; 2022 Jul; 23(7):e54339. PubMed ID: 35574994
[TBL] [Abstract][Full Text] [Related]
8. Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients.
Lasigliè D; Traggiai E; Federici S; Alessio M; Buoncompagni A; Accogli A; Chiesa S; Penco F; Martini A; Gattorno M
PLoS One; 2011; 6(5):e20014. PubMed ID: 21637346
[TBL] [Abstract][Full Text] [Related]
9. Cryo-sensitive aggregation triggers NLRP3 inflammasome assembly in cryopyrin-associated periodic syndrome.
Karasawa T; Komada T; Yamada N; Aizawa E; Mizushina Y; Watanabe S; Baatarjav C; Matsumura T; Takahashi M
Elife; 2022 May; 11():. PubMed ID: 35616535
[TBL] [Abstract][Full Text] [Related]
10. Low-frequency mosaicism in cryopyrin-associated periodic fever syndrome: mosaicism in systemic autoinflammatory diseases.
Nishikomori R; Izawa K; Kambe N; Ohara O; Yasumi T
Int Immunol; 2019 Sep; 31(10):649-655. PubMed ID: 31185077
[TBL] [Abstract][Full Text] [Related]
11. Gain of function mutation and inflammasome driven diseases in human and mouse models.
Cordero MD; Alcocer-Gómez E; Ryffel B
J Autoimmun; 2018 Jul; 91():13-22. PubMed ID: 29610014
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production.
Molina-López C; Hurtado-Navarro L; García CJ; Angosto-Bazarra D; Vallejo F; Tapia-Abellán A; Marques-Soares JR; Vargas C; Bujan-Rivas S; Tomás-Barberán FA; Arostegui JI; Pelegrin P
Nat Commun; 2024 Feb; 15(1):1096. PubMed ID: 38321014
[TBL] [Abstract][Full Text] [Related]
13. Increased Prevalence of
Theodoropoulou K; Wittkowski H; Busso N; Von Scheven-Gête A; Moix I; Vanoni F; Hengten V; Horneff G; Haas JP; Fischer N; Palm-Beden K; Berendes R; Heubner G; Jansson A; Lainka E; Leimgruber A; Morris M; Foell D; Hofer M
Front Immunol; 2020; 11():877. PubMed ID: 32477355
[No Abstract] [Full Text] [Related]
14. NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies.
Moltrasio C; Romagnuolo M; Marzano AV
Front Immunol; 2022; 13():1007705. PubMed ID: 36275641
[TBL] [Abstract][Full Text] [Related]
15. Confounding role of tumor necrosis factor in cryopyrin-associated periodic syndromes.
Banoth B; Sutterwala FS
J Clin Invest; 2017 Dec; 127(12):4235-4237. PubMed ID: 29130931
[TBL] [Abstract][Full Text] [Related]
16. Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.
Brydges SD; Broderick L; McGeough MD; Pena CA; Mueller JL; Hoffman HM
J Clin Invest; 2013 Nov; 123(11):4695-705. PubMed ID: 24084736
[TBL] [Abstract][Full Text] [Related]
17. A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome.
Hu J; Zhu Y; Zhang JZ; Zhang RG; Li HM
Chin Med J (Engl); 2017 Mar; 130(5):586-593. PubMed ID: 28229991
[TBL] [Abstract][Full Text] [Related]
18. Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance.
Carta S; Penco F; Lavieri R; Martini A; Dinarello CA; Gattorno M; Rubartelli A
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2835-40. PubMed ID: 25730877
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations.
Mortimer L; Moreau F; MacDonald JA; Chadee K
Nat Immunol; 2016 Oct; 17(10):1176-86. PubMed ID: 27548431
[TBL] [Abstract][Full Text] [Related]
20. Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.
Tengesdal IW; Menon DR; Osborne DG; Neff CP; Powers NE; Gamboni F; Mauro AG; D'Alessandro A; Stefanoni D; Henen MA; Mills TS; De Graaf DM; Azam T; Vogeli B; Palmer BE; Pietras EM; DeGregori J; Tan AC; Joosten LAB; Fujita M; Dinarello CA; Marchetti C
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
